In 2023, Italy held the highest share of high growth enterprises in pharmaceutical preparations in Europe, demonstrating moderate growth of 3.96%. The Czech Republic and Portugal showcased substantial increases with 28.99% and 18.29% respectively, highlighting their burgeoning pharmaceutical sectors. Latvia marked the most significant rise at 51.57%, indicating a robust expansion. Conversely, Hungary and Slovakia experienced dips of 2.64% and 4.36%, pointing to a potential stagnation or retraction. In Lithuania, a positive trend emerged with a 25.74% increment, while Romania, Norway, and Iceland showed no year-on-year variations.
For future trends, it is crucial to monitor the continued expansion in the Czech Republic and Latvia, as their growth trajectories suggest increased competitiveness in the European pharmaceutical industry. Additionally, Italy’s stable position necessitates scrutiny for potential challenges to its dominance, while the declining performance of Hungary and Slovakia may require strategic interventions to foster renewed growth.
Top countries in Number of High Growth Enterprises in Pharmaceutical Preparations Share by Country (Units (Enterprises))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 38.37 | 2023 | -1.92% | +3.96% | View data |
| 2 | 2 Czech Republic | 18.81 | 2023 | +8.7% | +28.99% | View data |
| 3 | 3 Portugal | 16.55 | 2023 | +10% | +18.29% | View data |
| 4 | 4 Latvia | 6.02 | 2023 | +14.29% | +51.57% | View data |
| 5 | 5 Hungary | 5.27 | 2023 | 0% | -2.64% | View data |
| 6 | 6 Lithuania | 3.76 | 2023 | +25% | +25.74% | View data |
| 7 | 7 Slovakia | 3.01 | 2023 | 0% | -4.36% | View data |
| 8 | 8 Romania | 2.26 | 2023 | 0% | 0% | View data |
| 9 | 9 Norway | 1.5 | 2023 | 0% | 0% | View data |
| 10 | 10 Iceland | 1.5 | 2023 | 0% | 0% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...